Lexeo Therapeutics, Inc. (LXEO)

NASDAQ: LXEO · IEX Real-Time Price · USD

14.02

-1.59 (-10.19%)

At close: Jul 2, 2024, 4:00 PM

14.72

+0.70 (4.99%)

After-hours: Jul 2, 2024, 7:19 PM EDT

Lexeo Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022
Market Capitalization	462	358	-
Enterprise Value	275	245	-67
PE Ratio	-	-5.39	-
PB Ratio	2.52	3.15	-
P/FCF Ratio	-	-6.00	-
P/OCF Ratio	-	-6.01	-
EV/Sales Ratio	-	-	-102.61
EV/EBITDA Ratio	-	-3.80	1.16
EV/EBIT Ratio	-3.34	-3.69	1.13
EV/FCF Ratio	-	-4.10	1.21
Debt / Equity Ratio	0.06	0.10	-0.12
Debt / EBITDA Ratio	-	-0.18	-0.23
Debt / FCF Ratio	-	-0.20	-0.24
Quick Ratio	9.17	7.23	5.62
Current Ratio	9.16	7.21	5.58
Asset Turnover	0	0	0.01
Interest Coverage	-360.55	-322.87	-650.40
Return on Equity (ROE)	2792.90%	-22855.10%	70.30%
Return on Assets (ROA)	-58.70%	-56.10%	-50.70%
Return on Capital (ROIC)	-37.34%	-54.73%	60.83%
Earnings Yield	-15.03%	-18.57%	-
FCF Yield	-16.67%	-
Buyback Yield / Dilution	-1637.02%	-228.42%	-5.00%
Total Shareholder Return	-1637.02%	-228.42%	-5.00%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).